Literature DB >> 15829582

Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism.

Katarzyna Lundmark1, Gunilla T Westermark, Arne Olsén, Per Westermark.   

Abstract

Secondary, or amyloid protein A (AA), amyloidosis is a complication of chronic inflammatory diseases, both infectious and noninfectious. AA constitutes the insoluble fibrils, which are deposited in different organs, and is a major N-terminal part of the acute phase protein serum AA. It is not known why only some patients with chronic inflammation develop AA amyloidosis. Nucleation is a widely accepted mechanism in amyloidogenesis. Preformed amyloid-like fibrils act as nuclei in amyloid fibril formation in vitro, and AA amyloid fibrils and synthetic amyloid-like fibrils also may serve as seed for fibril formation in vivo. In addition to amyloid fibrils, there is a variety of similar nonmammalian protein fibrils with beta-pleated structure in nature. We studied three such naturally occurring protein fibrils: silk from Bombyx mori, Sup35 from Saccharomyces cerevisiae, and curli from Escherichia coli. Our results show that these protein fibrils exert amyloid-accelerating properties in the murine experimental AA amyloidosis, suggesting that such environment factors may be important risk factors in amyloidogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829582      PMCID: PMC1087940          DOI: 10.1073/pnas.0501814102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Oligopeptide-repeat expansions modulate 'protein-only' inheritance in yeast.

Authors:  J J Liu; S Lindquist
Journal:  Nature       Date:  1999-08-05       Impact factor: 49.962

2.  Heterologous transfer of amyloid--human to mouse.

Authors:  T Shirahama; O J Lawless; A S Cohen
Journal:  Proc Soc Exp Biol Med       Date:  1969-02

3.  Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy.

Authors:  R Kisilevsky; L Boudreau
Journal:  Lab Invest       Date:  1983-01       Impact factor: 5.662

4.  Amyloidosis in mice produced by transplantation of spleen cells from casein-treated mice.

Authors:  O Werdelin; P Ranlov
Journal:  Acta Pathol Microbiol Scand       Date:  1966

5.  Nucleated conformational conversion and the replication of conformational information by a prion determinant.

Authors:  T R Serio; A G Cashikar; A S Kowal; G J Sawicki; J J Moslehi; L Serpell; M F Arnsdorf; S L Lindquist
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

6.  Transmissibility of systemic amyloidosis by a prion-like mechanism.

Authors:  Katarzyna Lundmark; Gunilla T Westermark; Sofia Nyström; Charles L Murphy; Alan Solomon; Per Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

7.  Association of amyloidosis with erythema nodosum leprosum reactions and recurrent neutrophil leucocytosis in leprosy.

Authors:  K P McAdam; R F Anders; S R Smith; D A Russell; M A Price
Journal:  Lancet       Date:  1975-09-27       Impact factor: 79.321

8.  Tissue distribution, biochemical properties, and transmission of mouse type A AApoAII amyloid fibrils.

Authors:  Tatsumi Korenaga; Xiaoying Fu; Yanming Xing; Takatoshi Matsusita; Kazunao Kuramoto; Seigo Syumiya; Kazuhiro Hasegawa; Hironobu Naiki; Masaki Ueno; Tokuhiro Ishihara; Masanori Hosokawa; Masayuki Mori; Keiichi Higuchi
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Transfer amyloidosis. Local and systemic amyloidosis in recipients of syngeneic spleen grafts from non-amyloidotic, casein-sensitized donor mice.

Authors:  F Hardt; P Ranlov
Journal:  Acta Pathol Microbiol Scand       Date:  1968

10.  Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils.

Authors:  Xiaoying Fu; Tatsumi Korenaga; Li Fu; Yanming Xing; Zhanjun Guo; Takatoshi Matsushita; Masanori Hosokawa; Hironobu Naiki; Satoshi Baba; Yasushi Kawata; Shu-Ichi Ikeda; Tokuhiro Ishihara; Masayuki Mori; Keiichi Higuchi
Journal:  FEBS Lett       Date:  2004-04-09       Impact factor: 4.124

View more
  87 in total

Review 1.  [Cutaneous amyloidosis].

Authors:  S Schreml; R-M Szeimies; M Landthaler; P Babilas
Journal:  Hautarzt       Date:  2011-01       Impact factor: 0.751

2.  Functional amyloid: turning swords into plowshares.

Authors:  Daniel Otzen
Journal:  Prion       Date:  2010-10-17       Impact factor: 3.931

3.  In vitro polymerization of a functional Escherichia coli amyloid protein.

Authors:  Xuan Wang; Daniel R Smith; Jonathan W Jones; Matthew R Chapman
Journal:  J Biol Chem       Date:  2006-12-12       Impact factor: 5.157

Review 4.  Structural basis of infectious and non-infectious amyloids.

Authors:  Ulrich Baxa
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 5.  [Amyloid and amyloidoses].

Authors:  C Röcken; M Eriksson
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

6.  Prion-like disorders: blurring the divide between transmissibility and infectivity.

Authors:  Mimi Cushman; Brian S Johnson; Oliver D King; Aaron D Gitler; James Shorter
Journal:  J Cell Sci       Date:  2010-04-15       Impact factor: 5.285

7.  Very long term studies of the seeding of beta-amyloidosis in primates.

Authors:  R M Ridley; H F Baker; C P Windle; R M Cummings
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

8.  Cloning and Aggregation Characterization of Rubber Elongation Factor and Small Rubber Particle Protein from Ficus carica.

Authors:  Saki Yokota; Yurina Suzuki; Keisuke Saitoh; Sakihito Kitajima; Norimasa Ohya; Takeshi Gotoh
Journal:  Mol Biotechnol       Date:  2018-02       Impact factor: 2.695

9.  Amyloidogenic potential of foie gras.

Authors:  Alan Solomon; Tina Richey; Charles L Murphy; Deborah T Weiss; Jonathan S Wall; Gunilla T Westermark; Per Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

10.  Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.

Authors:  Saipraveen Srinivasan; Sanket Patke; Yun Wang; Zhuqiu Ye; Jeffrey Litt; Sunit K Srivastava; Maria M Lopez; Dmitry Kurouski; Igor K Lednev; Ravi S Kane; Wilfredo Colón
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.